This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dalal, B. I. Articles by Greenberg, A. H. Search for Related Content PubMed PubMed Citation Articles by Dalal, B. I. Articles by Greenberg, A. H.

American Journal of Pathology, Vol 143, 381-389, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Immunocytochemical localization of secreted transforming growth factor- beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma

BI Dalal, PA Keown and AH Greenberg
Department of Pathology, Vancouver General Hospital, Canada.

The level of expression and localization of transforming growth factor- beta 1 (TGF-beta 1) were analyzed by immunocytochemistry using antibodies that distinguished the sites of intracellular synthesis and extracellular secretion of TGF-beta 1 in 28 cases of infiltrating duct carcinoma of breast, 12 of which had lymph node metastases. Twenty- seven of 28 primary tumors and all 12 lymph node metastases showed extracellular deposition of TGF-beta 1. The extracellular TGF-beta 1 staining was either confined to or more strongly expressed at the advancing edges of the tumor than in the center of the primary tumor. By contrast, 19 of 28 primary tumors and 11 of 12 metastases contained intracellular TGF-beta 1, and no variation in the intensity was seen. The metastatic tumors were significantly more intensely stained for both intra- and extracellular TGF-beta 1 than the primary tumor tissues. The preferential expression of secreted TGF-beta 1 at the advancing tumor edges and in lymph node metastases suggests a role for TGF-beta 1 in the malignant progression of breast carcinoma.

This article has been cited by other articles:

				S. H. Wrzesinski, Y. Y. Wan, and R. A. Flavell Transforming Growth Factor-{beta} and the Immune Response: Implications for Anticancer Therapy Clin. Cancer Res., September 15, 2007; 13(18): 5262 - 5270. [Abstract] [Full Text] [PDF]

				J. Beisner, M. B. Buck, P. Fritz, J. Dippon, M. Schwab, H. Brauch, G. Zugmaier, K. Pfizenmaier, and C. Knabbe A Novel Functional Polymorphism in the Transforming Growth Factor-{beta}2 Gene Promoter and Tumor Progression in Breast Cancer. Cancer Res., August 1, 2006; 66(15): 7554 - 7561. [Abstract] [Full Text] [PDF]

				M. C Fleisch, C. A Maxwell, and M.-H. Barcellos-Hoff The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr. Relat. Cancer, June 1, 2006; 13(2): 379 - 400. [Abstract] [Full Text] [PDF]

				T. X. Pedersen, C. J. Pennington, K. Almholt, I. J. Christensen, B. S. Nielsen, D. R. Edwards, J. Romer, K. Dano, and M. Johnsen Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas Carcinogenesis, July 1, 2005; 26(7): 1233 - 1240. [Abstract] [Full Text] [PDF]

				S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Crit. Rev. Oral. Biol. Med., November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF]

				C. Denicourt and S. F. Dowdy Another twist in the transforming growth factor {beta}-induced cell-cycle arrest chronicle PNAS, December 23, 2003; 100(26): 15290 - 15291. [Full Text] [PDF]

				F. Tian, S. DaCosta Byfield, W. T. Parks, S. Yoo, A. Felici, B. Tang, E. Piek, L. M. Wakefield, and A. B. Roberts Reduction in Smad2/3 Signaling Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines Cancer Res., December 1, 2003; 63(23): 8284 - 8292. [Abstract] [Full Text] [PDF]

				A. B. Roberts and L. M. Wakefield The two faces of transforming growth factor {beta} in carcinogenesis PNAS, July 22, 2003; 100(15): 8621 - 8623. [Full Text] [PDF]

				J. Czuwara-Ladykowska, V. I. Sementchenko, D. K. Watson, and M. Trojanowska Ets1 Is an Effector of the Transforming Growth Factor beta (TGF-beta ) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-beta J. Biol. Chem., May 31, 2002; 277(23): 20399 - 20408. [Abstract] [Full Text] [PDF]

				Y.-a. Yang, B. Tang, G. Robinson, L. Hennighausen, S. G. Brodie, C.-X. Deng, and L. M. Wakefield Smad3 in the Mammary Epithelium Has a Nonredundant Role in the Induction of Apoptosis, but not in the Regulation of Proliferation or Differentiation by Transforming Growth Factor-{beta} Cell Growth Differ., March 1, 2002; 13(3): 123 - 130. [Abstract] [Full Text] [PDF]

				W. Xie, J. C. Mertens, D. J. Reiss, D. L. Rimm, R. L. Camp, B. G. Haffty, and M. Reiss Alterations of Smad Signaling in Human Breast Carcinoma Are Associated with Poor Outcome: A Tissue Microarray Study Cancer Res., January 1, 2002; 62(2): 497 - 505. [Abstract] [Full Text] [PDF]

				A. Bandyopadhyay, Y. Zhu, M. L. Cibull, L. Bao, C. Chen, and L. Sun A Soluble Transforming Growth Factor {beta} Type III Receptor Suppresses Tumorigenicity and Metastasis of Human Breast Cancer MDA-MB-231 Cells Cancer Res., October 1, 1999; 59(19): 5041 - 5046. [Abstract] [Full Text] [PDF]

				Y. Maehara, Y. Kakeji, A. Kabashima, Y. Emi, A. Watanabe, K. Akazawa, H. Baba, S. Kohnoe, and K. Sugimachi Role of Transforming Growth Factor-{beta}1 in Invasion and Metastasis in Gastric Carcinoma J. Clin. Oncol., February 1, 1999; 17(2): 607 - 607. [Abstract] [Full Text] [PDF]